Multiple cytochrome P450-isoenzymes mRNA are expressed in dendritic cells

International Archives of Allergy and Immunology

Volumn 118, Issue 2-4, 1999, Pages 358-361

  Sieben, S ^a   Baron, J M ^a   Blomeke B ^a   Merk, Hans F ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Antigen presenting cells; Cytochrome P450; Dendritic cells

Indexed keywords

CYTOCHROME P450; ISOENZYME; MESSENGER RNA;

ANTIGEN PRESENTING CELL; CONFERENCE PAPER; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL;

EID: 0032964232     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024135     Document Type: Conference Paper

References (14)

1. Martin S, Weltzien HU: T cell recognition of haptens, a molecular view. Int Arch Allergy Immunol 1994;104:10-15.
2. Merk H, Hertl M: Immunological mechanisms of cutaneous drug reactions. Semin Cutan Med Surg 1996;15:228-235.
3. Basketter DA, Pendlington RU, Sarll A, Scholes E: The role of P4501A1 in the activation of prohaptens in skin sensitization. J Invest Dermatol 1996;106:915(A).
4. Meyer UA, Zanger U: Molecular mechanisms of polymorphism of drug metabolism. Annu Rev Pharmacol Toxicol 1997;37:269-296.
5. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH: Proinflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997;27:3135-3142.
6. Rannug A, Alexandrie AK, Persson I, Ingelman Sundberg M: Genetic polymorphism of cytochrome P4501A1, 2D6 and 2E1: Regulation and toxicological significance. J Occup Environ Med 1995;37:25-36.
7. 30-latex. Nucleic Acids Res Symp Series 1988; 19:61-64.
8. Baron JM, Zwadlo-Klarwasser G, Jugert F, Hamann W, Rübben A, Mukhtar H, Merk HF: Cytochrome P4501B1: a major P450 isoenzyme in human blood monocytes and macrophages subsets. Biochem Pharmacol 1998; 56:1105-1110.
9. Hakkola J, Pasanen M, Purkunen R, Saarkoski S, Pelkonen O. Mäenpää J, Rane A, Raunio H: Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol 1994;48:59-64.
10. Sutter TR, Tang YM, Hayes CL, Wo YP, Jabs W, Li X, Yin H, Cody CW, Greenlee WF: Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 1994;269:13092-13099.
11. Tang YM, Wo YP, Stewart J, Hawkina AL, Griffin CA, Sutter TR, Greenlee WF: Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J Biol Chem 1996;271: 28324-28330.
12. Fujino T, Park SS, Gelboin HV: Phenotyping of cytochrome P-450 in human tissue with monoclonal antibodies. Proc Natl Acad Sci USA 1982;79:3682-3686.
13. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR: Activation of chemically diverse procarcinogens by human cytochrome P4501B1. Cancer Res 1996;56:2979-2984.
14. Puga A, Nebert DW, McKinnon RA, Menon AG: Genetic polymorphisms in human drug-metabolizing enyzmes. Potential uses of reverse genetics to identify genes of toxicological relevance. Crit Rev Toxical 1997;27:199-222.